Results 191 to 200 of about 741,475 (253)

Hepatitis Delta Virus and Hepatocellular Carcinoma. [PDF]

Pathogens
Lombardo D, Franzè MS, Caminiti G, Pollicino T.   +3 more
europepmc   +1 more source

Phase 2 Randomised Study of Bulevirtide as Monotherapy or Combined With Peg-IFNα-2a as Treatment for Chronic Hepatitis Delta. [PDF]

Liver Int
Lampertico P, Bogomolov PO, Chulanov V, Stepanova T, Morozov V, Allweiss L, Dandri M, Burhenne J, Blank A, Ciesek S, Elsner C, Dittmer U, An Q, Manuilov D, Da BL, Flaherty JF, Urban S, Wedemeyer H.   +17 more
europepmc   +1 more source

IFN-β production promotes metabolic rewiring and protection against oxidative stress in hepatitis delta virus-infected hepatocyte cultures. [PDF]

Cell Death Dis
Khomich OA, Giavalisco P, Parent R, Krasnov GS, Tessarz P, Meuleman P, Burm R, Zakirova NF, Molle J, Batbold E, Gottlieb E, Zoulim F, Ivanov AV, Bartosch B.   +13 more
europepmc   +1 more source

Impact of Low Hepatitis Delta Virus Screening Rates on the Accurate Estimation of Seroprevalence in Florida: A Retrospective Observational Study. [PDF]

Cureus
Prince SA, Gaddipati S, Martin P, Zarnegarnia Y, Jones PDD.   +4 more
europepmc   +1 more source

vHDvDB 2.0: Database and Group Comparison Server for Hepatitis Delta Virus. [PDF]

Viruses
Lee CC, Lau YC, Liang YK, Hsian YH, Lin CH, Wu HY, Tan DJY, Yeh YM, Chao M.   +8 more
europepmc   +1 more source

Growing Awareness: Limited Testing and Screening Bias for Hepatitis Delta Virus in Utah 2000-2021. [PDF]

J Infect Dis
Hesterman MC, Fallon BS, Lynch KM, Weller ML.   +3 more
europepmc   +1 more source